Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2020 Jul 8;20:486. doi: 10.1186/s12879-020-05197-y

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© The Author(s) 2020

Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

PMC Copyright notice

Fig. 2 — Mean interval (days) between the last reported sexual contact with women, the onset of urethral symptoms, testing and treatment in urethral Neisseria gonorrhoeae infections among heterosexual men stratified by symptom category. (1a) 93 (80.2%) men with typical discharge treated for gonorrhoea (azithromycin 1g plus ceftriaxone 500 mg) on the day of screening, 72 of them had time interval data reported. (2a) 9 (7.8%) men with atypical symptoms treated for gonorrhoea on the day of screening, 6 had time interval data reported; (2b) 7 (6.0%) men with atypical symptoms treated for non-gonococcal urethritis (azithromycin 1g or doxycycline 100 mg twice daily for 7 days) on the day of screening, 3 had time interval data reported. (3a) 4 (3.5%) men with no symptoms not treated for gonorrhoea on the day of screening, 2 had time interval data reported; (3b) 2 (1.7%) men with no symptoms treated for gonorrhoea on the day of screening, 1 had time interval data reported; (3c) 1 (0.9%) men with no symptoms on the day of screening but developed typical discharge later